BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2566543)

  • 1. Safety profile of H2-receptor antagonists: current status of famotidine.
    Levine JB
    J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].
    Andersen M; Schou JS
    Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famotidine and ranitidine, but not cimetidine, cause severe, disabling headache.
    Hirsch E
    Am J Gastroenterol; 1989 Feb; 84(2):202-3. PubMed ID: 2563629
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    Tomasko MA; Luskin AT
    Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of H2-receptor antagonists.
    Iberti TJ
    DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems associated with medical treatment of peptic ulcer disease.
    Zimmerman TW
    Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
    Andersen M; Schou JS
    Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro availability studies of enoxacin in presence of H2 receptor antagonists.
    Arayne MS; Sultana N; Haroon U; Hamza E
    Pak J Pharm Sci; 2007 Jul; 20(3):235-43. PubMed ID: 17545110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration].
    Takimoto R; Mogi Y; Kura T; Niitsu Y
    Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Side effects of ulcer treatment with cimetidine].
    Simon B; Müller P; Bertermann O; Kather H
    Med Klin; 1981 Jun; 76(13):362-5, 63. PubMed ID: 6114389
    [No Abstract]   [Full Text] [Related]  

  • 19. Do OTC 'ulcer drugs' pose problems when used with dental medications?
    Biron CR
    RDH; 1995 Dec; 15(12):25, 39. PubMed ID: 9534484
    [No Abstract]   [Full Text] [Related]  

  • 20. [The status of H2-blocker therapy today].
    Rameis H
    Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.